Annual Meeting Of Association Research Articles

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

On The 64rd Annual Meeting of the Japanese Association of Educational Psychology

On The 64rd Annual Meeting of the Japanese Association of Educational Psychology

Review of the 38th Annual Meeting of the European Association of Urology (EAU) 2023

WELCOMED by the graceful vocals of the Italian Tenors, Christopher Chapple, European Association of Urology (EAU) Secretary General, opened what he described as a “vibrant programme” at the 38th Annual EAU Congress, held in Milan, Italy between the 10th-13th March 2023. Boasting a rich history of art, architecture, and culture, and home to Leonardo da Vinci’s famous mural ‘The Last Supper’, over this weekend Milan traded its role as a global hub for fashion and design to host the largest urology event in Europe.

The growing clinical effect of SGLT2 inhibitors

In September, 2015, the results of EMPA-REG OUTCOME, the first cardiovascular outcomes study based on a sodium-glucose co-transporter-2 (SGLT2) inhibitor, empagliflozin, were announced at the Annual Meeting of the European Association for the Study of Diabetes. It was the first of a series of cardiovascular outcome studies confirming a significant risk reduction of the three-point MACE (cardiovascular mortality, non-fatal myocardial infarction, and non-fatal stroke) in people with type 2 diabetes and established atherosclerotic cardiovascular disease. It was also the first clinical trial to show potential renal protection: empagliflozin was associated with reduced loss of estimate glomerular filtration rate compared with placebo. Moreover, the trial reported a significant reduction in the risk of hospitalisation for heart failure. 1 Zinman B Wanner C Lachin JM et al. Investigators E-ROEmpagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015; 373: 2117-2128 Crossref PubMed Scopus (7211) Google Scholar The cardiorenal protective effects of SGLT2 inhibitors have been confirmed in subsequent cardiovascular outcomes studies done in people with type 2 diabetes 2 McGuire DK Shih WJ Cosentino F et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021; 6: 148-158 Crossref PubMed Scopus (339) Google Scholar and without diabetes. 3 Vaduganathan M Docherty KF Claggett BL et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022; 400: 757-767 Summary Full Text Full Text PDF PubMed Scopus (61) Google Scholar Because of these results, current guidelines recommend the use of a SGLT2 inhibitor with proven beneficial effect for people with type 2 diabetes with chronic kidney disease and a history of heart failure. 4 Davies MJ Aroda VR Collins BS et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022; 65: 1925-1966 Crossref PubMed Scopus (32) Google Scholar Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trialDapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on health-care costs attributable this condition. Full-Text PDF

Abstracts

Abstracts

Power of PTAIR 2.0 in Prediction, Identification, and Ischemia Assessment of the Parathyroid Gland Under Endoscopic Thyroid Surgery

Objective: This video demonstrates the use of PTAIR 2.0, which is an artificial intelligence model for the prediction, identification, and ischemia assessment of parathyroid glands in endoscopic thyroid surgery. Methods: PTAIR 2.0 is an artificial intelligence model for parathyroid gland recognition during surgery. In total, 1641 patients who underwent endoscopic thyroid surgery at our hospital from August 2012 to December 2021 were selected. YOLOX was used to train this version. The hindsight strategy was used for the labeling of parathyroid gland prediction data.1–3 Results: PTAIR achieved the AP50 values for the prediction, identification, and ischemia assessment of the parathyroid glands of 94.1%, 98.9%, and 92.1%, respectively. Conclusions: PTAIR, which was established through computer vision, provides a novel methodology for the prediction, identification, and ischemia assessment of parathyroid glands in endoscopic thyroid surgery. PTAIR can be used to detect parathyroid glands and provide decision-making in the autotransplantation of parathyroid glands in endoscopic thyroid surgery. Acknowledgments: On behalf of the PTAIR Research Group, Yi-Jian Li from Fuzhou University, Jun-Yi Huang and Chi-Peng Zhou from Fujian Medical University Union Hospital, and Jing Zheng from Zhangzhou Affiliated Hospital of Fujian Medical University have also contributed to this video. Si-Ying Lin, Meng-Yao Li, and Jia-Fan Yu contributed equally to this study and are considered co-first authors. PTAIR is a registered trademark of Fujian Medical University Union Hospital. All other authors have no conflicts of interest to disclose. Funding Information: This research was supported by the China Scholarship Council; the Joint Funds for the Innovation of Science and Technology, Fujian Province (Grant Nos. 2018Y9093, 2018Y0915, and 2018Y9018); sponsored by Fujian Provincial Health Technology Project (Grant Nos. 2019-CX-16 and 2018-CX-17). Runtime of video: 3 mins 23 secs An abstract based on this video was posted for presentation at the 2022 American Thyroid Association Annual Meeting.

Abstracts

Cancer ScienceVolume 114, Issue S1 p. 1-2317 AbstractsOpen Access Abstracts First published: 15 February 2023 https://doi.org/10.1111/cas.15742AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume114, IssueS1Special Issue: Abstracts of the 81st Annual Meeting of the Japanese Cancer Association; 2022 Sep 29 ‐ Oct 1; Yokohama, JapanFebruary 2023Pages 1-2317 RelatedInformation

Literature as an Exotic Substance in Pre-Modern Literate Societies

This text was written for the "Seminar: World Literature: Circulations Outside the Modern” organized by Alexander Beecroft and Galin Tihanov at the ACLA (online) meeting on April 11, 2021 (Annual Meeting of the American Comparative Literature Association).

Proceedings of the 69th Annual Meeting of the Japanese Group Dynamics Association

Proceedings of the 69th Annual Meeting of the Japanese Group Dynamics Association

Industry Update, October 2022.

Industry Update, October 2022.

Publication Rates of Podium Presentations from the Orthopedic Summit: Fellow Resident and Medical Student Annual Meeting 2019-2021

Purpose To determine the publication rate of presentations presented at the Orthopaedic Summit and Evolving Techniques (OSET) Fellow Resident and Medical Student Annual Meeting 2019-2021 Methods All presentations from the OSET annual meeting between 2019 -2021 were identified from the OSET’s official website and confirmed through review of the OSET Official Programs. The 2019 and 2021 meeting were in person and the 2020 meeting was virtual due to the COVID pandemic. This information was then used to direct a search on PubMed and Google Scholar database to determine if the presentation was associated with a publication since the meeting. Publishing information was entered into the database. Results For 2019-2021 there were a total of 227 presentations with 101 associated publications (45%). The highest rate of publications was 63% of presentations published in 2019, followed by 49% rate of publications in 2020, and 27% rate of publications in 2021. The presentations were published at an average of 8.1 months after presentation. Conclusion Our research demonstrated a 45% publication rate over a 3-year period of presentations presented at the OSET annual meetings. Our results are comparable to other publication rates for podium presentations in other societies (e.g. American Academy of Orthopaedic Surgeons, Annual Meeting of the Pediatric Orthopedic Society of North America, Orthopedic Trauma Association Annual Meeting, American Academy for Surgery of the Hand, Annual Meetings of the North American Spine Society, and American Orthopedic Society for Sports Medicine Annual Meeting). This validates the quality of research presented in podium presentations format at the OSET Annual Meeting.

Implications of Elevated Postprandial Glucose and Nutritional Approaches for Postprandial Glucose Management with a Focus on Whey Proteins

This symposium took place at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden. The first speaker was John L. Sievenpiper, who discussed the pathophysiology of postprandial hyperglycaemia and how it may impact the risk of cardiovascular disease (CVD), peripheral vascular disease, insulin resistance, and other comorbidities in patients with Type 2 diabetes (T2D). Sievenpiper then reviewed various pharmacological interventions that target postprandial glucose (PPG) and insulin levels, including incretin therapies and α-glucosidase inhibitors, such as acarbose. Data presented showed that a low glycaemic index (GI) diet can improve glycaemic control and reduce cardiometabolic risk factors in patients with Type 1 diabetes (T1D) and T2D. Sievenpiper then presented data on novel non-pharmacological approaches that target PPG, including mulberry leaf (Morus alba L) extract (MLE), which has α-glucosidase inhibitor activity, reducing PPG and insulin responses to sucrose. The second speaker, Bo Ahrén, presented data on the effects of whey protein (WP) and branched-chain amino acids (BCAA) on PPG management and as a potential intervention for postprandial hyperglycaemia. They also discussed the mechanisms underlying the effects of WP, and highlighted data presented at the 2022 58th Annual EASD meeting by Johansen and colleagues on a novel micelle microgel technology. WP microgels (WPM) deliver highly concentrated and lower calorie doses of WP, with the potential to be developed clinically as therapeutics for T2D. The symposium concluded with a question and answer session between panel members and the audience. Ian J. Neeland was the meeting moderator.

Implications of Elevated Postprandial Glucose and Nutritional Approaches for Postprandial Glucose Management with a Focus on Whey Proteins

This symposium took place at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden. The first speaker was John L. Sievenpiper, who discussed the pathophysiology of postprandial hyperglycaemia and how it may impact the risk of cardiovascular disease (CVD), peripheral vascular disease, insulin resistance, and other comorbidities in patients with Type 2 diabetes (T2D). Sievenpiper then reviewed various pharmacological interventions that target postprandial glucose (PPG) and insulin levels, including incretin therapies and α-glucosidase inhibitors, such as acarbose. Data presented showed that a low glycaemic index (GI) diet can improve glycaemic control and reduce cardiometabolic risk factors in patients with Type 1 diabetes (T1D) and T2D. Sievenpiper then presented data on novel non-pharmacological approaches that target PPG, including mulberry leaf (Morus alba L) extract (MLE), which has α-glucosidase inhibitor activity, reducing PPG and insulin responses to sucrose. The second speaker, Bo Ahrén, presented data on the effects of whey protein (WP) and branched-chain amino acids (BCAA) on PPG management and as a potential intervention for postprandial hyperglycaemia. They also discussed the mechanisms underlying the effects of WP, and highlighted data presented at the 2022 58th Annual EASD meeting by Johansen and colleagues on a novel micelle microgel technology. WP microgels (WPM) deliver highly concentrated and lower calorie doses of WP, with the potential to be developed clinically as therapeutics for T2D. The symposium concluded with a question and answer session between panel members and the audience. Ian J. Neeland was the meeting moderator.

The scholarship of teaching and learning: Understanding the concept and its application in academic programs and emergency management.

For years, education has gone through transformation and incorporated innovation to improve the effectiveness of teaching and learning. The scholarship of teaching and learning (SoTL) is one such activity that transforms and innovates education to engineer effectiveness. SoTL is internationally accepted and applied in Education, Psychology, Management Science, Chemistry, History, English, Sociology, Communication Studies, Mathematics, Engineering, Medicine, and Interdisciplinary Programs with a growing interest in Emergency Management and Homeland Security (EMHS). In relation to the EMHS programs, the Federal Emergency Management Agency (FEMA) SoTL Special Interest Group members have participated in the American Educational Research Association annual meetings and then shared the relevance of the SoTL concept with the EM scholars, researchers, and practitioners at the FEMA Higher Education programs.1-4 Thus, the concept of SoTL cuts across academic barriers with methodological pluralism in educational practice. In addition, the success of SoTL has been driven with the publication of two edited volumes of Carnegie Scholars' works: (1) Opening Lines: Approaches to the Scholarship of Teaching and Learning5 and (2) Disciplinary Styles in the Scholarship of Teaching and Learning: Exploring Common Ground.6 However, even with these advances, there are some concerns about SoTL critiques. One such critique comes from Boshier who asserts that SoTL is a difficult academic concept to be accepted by the academic community.7 Criticisms -notwithstanding, there are many benefits due to SoTL. Its future is bright and encouraging as nations benefit from SoTL's educational transformative and innovative power.

Symposium: Better teaching through science: incorporating the scholarship of teaching & learning

The Scholarship of Teaching and Learning, also referred to as SOTL, provides a framework for instructors to evaluate student learning and use evidence to determine pedagogical changes in the classroom. Engagement in SOTL challenges scholars to ask questions about their teaching practices and share with a larger community of practice. Examples of this include manuscript submissions to peer-reviewed journals, presenting abstracts at conferences, and other outlets that allow scholars to disseminate their findings. SOTL practices can be applied within an individual classroom or across a curriculum. Additionally, the promotion and tenure process at many institutions of higher education are highly recommending that faculty demonstrate impact on student learning. This symposium, presented at the 2022 Poultry Science Association Annual Meeting, highlighted best practices in SOTL, implementation of SOTL programming, and discussed using SOTL as a tool to evaluate teaching effectiveness. Poultry and animal science educators shared their experiences with implementing SOTL in their classroom and the benefits to students. From this symposium, we can conclude that there are multiple ways to document teaching excellence and conduct SOTL projects. This is of interest to educators implementing scholarly teaching in their classrooms.

Attack by a Turkey: Learning to Write History from Bernard Bailyn

Attack by a Turkey: Learning to Write History from Bernard Bailyn

Physiatrists' Attitudes and Knowledge About Cancer Rehabilitation.

ObjectiveWe aim to assess the awareness and evaluation pattern among physiatrists regarding cancer rehabilitation and associated barriers to access.DesignThe present study is a cross-sectional study in the Physical Medicine and Rehabilitation (PMR) Association Annual Meeting in Puerto Rico that used a 10-item questionnaire to summarize physiatrists’ clinical patterns with their persons diagnosed with cancer (PDWCs).ResultsThirty-eight (66.7%) participants answered they received minimal to no education about cancer rehabilitation benefits. Cancer patients represented 10% or less of the weekly patient load for 47 (82.5%) physiatrists surveyed. The most common type of cancer encountered was breast cancer for the management of adverse effects. Twenty-nine (50.9%) physiatrists answered that a multifactorial barrier was the cause for limited services within this population group. All participants agreed that rehabilitation is at least sometimes beneficial for cancer patients, and 54 (94.7%) believed these services are needed.ConclusionAlthough rehabilitation specialists learn about the benefits of rehabilitation for PDWCs, there continues to be a limited number of PDWCs evaluated, mainly due to poor access, lack of information about cancer rehabilitation, and economic difficulties. Further efforts should be made to emphasize the importance of integrating rehabilitation techniques in the care of PDWCs.

58th EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.

58th EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.

91st American Thyroid Association Annual Meeting Preview: Live and in Person in Montréal! October 19–23, 2022 Montréal, Quebec, Canada

91st American Thyroid Association Annual Meeting Preview: Live and in Person in Montréal! October 19–23, 2022 Montréal, Quebec, Canada

重症急性膵炎に対する予防的抗菌薬使用の現況 第49回日本救急医学会総会・学術集会より(Current status of prophylactic antimicrobial use for severe acute pancreatitis: in the 49th Annual Meeting of the Japanese Association for Acute Medicine)

要旨【背景】急性膵炎診療における予防的抗菌薬投与に関して，世界のガイドラインでは投与は非推奨となりつつあるが，日本の多くの施設では重症度に関わらず予防的抗菌薬は投与されている。施設ごとの診療パターンや，投与を支持するかしないかの背景にある根拠や臨床的動機は不明であり，第49回日本救急医学会総会学術集会で本命題に関するセッションが開催された。【目的】各演者の発表・討論内容，会場の投票結果を提示し，予防的抗菌薬投与の是非を検討する。【方法】発表要旨と質疑，投票結果の推移を記述した。【結果】Pros：抗菌薬の予防的投与と治療的投与を明確に区別するのは難しく，胆石性膵炎疑い例，医療暴露（耐性菌）（高感染リスク）例には，厳選して短期間（3日間）使用するべき。Cons：感染の証拠が明確でなければ使用するべきではない。投票結果推移：（軽症膵炎）非投与派が80%から90%に増加。（重症膵炎）投与派が77%から42%に減少。【考察】ガイドライン遵守率の低さと予防的抗菌薬投与の臨床的動機が判明した。世界のエビデンスやガイドライン推奨を正しく提示することで，行動変容が可能であることが示唆された。今後のガイドラインには，無菌性急性膵炎と胆管炎・敗血症併発の鑑別に関する指針や，その遵守率の定期的調査が求められる。【結論】予防的抗菌薬投与が推奨されなくなった事実を理解し，日本の最新版ガイドラインの遵守に努めるべきである。